Compare Avalanche Treasury Corporation Class A Common Stock (AVAT) vs Mesoblast Limited (MESO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Avalanche Treasury Corporation Class A Common Stock vs Mesoblast Limited — how do they compare? Avalanche Treasury Corporation Class A Common Stock trades at $0.34 (market cap $15.33M), while Mesoblast Limited trades at $16.96 (market cap $2.21B). The key difference: Mesoblast Limited is far larger — about 144.2× Avalanche Treasury Corporation Class A Common Stock's market cap, and Mesoblast Limited is trading nearer its 52-week high, Avalanche Treasury Corporation Class A Common Stock nearer its low. Which is the better fit depends on your goals.
| AVAT | MESO | |
|---|---|---|
Market Cap | $15.33M | $2.21B |
Sector | Financials | Technology |
52-Week High | $10.75 | $20.96 |
52-Week Low | $0.30 | $12.88 |
Enterprise Value | $15.33M | $2.21B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Avalanche Treasury Corporation Class A Common Stock
Avalanche Treasury Corp operates as a digital asset treasury company focused on holding and managing digital asset investments. The company was founded on September 22, 2025, and is headquartered in New York, NY.
Read more on AVAT →About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →
